NASDAQ:NKTR

Nektar Therapeutics Stock Predictions

etoro logo Buy NKTR
*Your capital is at risk
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NKTR Prediction Chart

NKTR Predictions History

Latest community submissions for NKTR.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 15, 2024 $1.30 -1.70% $1.29 V 99.42% 4
Oct 15, 2024 $1.28 -2.73% $1.29 V 99.53% 5
thedean2010 thedean2010 Merchant
Oct 15, 2024 Bullish $1.29 X 0
Oct 14, 2019 Bullish $15.87 X 0
Chaser Chaser Pro
Sep 5, 2019 $17.68 +1.78% $17.37 X 98.22% 0
Chaser Chaser Pro
Sep 3, 2019 $17.73 +4.85% $16.91 X 95.15% 0
Chaser Chaser Pro
Aug 30, 2019 $18.05 +2.73% $17.57 X 97.27% 0
Chaser Chaser Pro
Aug 12, 2019 $18.30 -1.51% $18.58 X 98.49% 0
Chaser Chaser Pro
Jun 20, 2019 $36.17 +2.20% $35.39 X 97.80% 0
Chaser Chaser Pro
Jun 10, 2019 $32.64 -1.48% $33.13 X 98.52% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NEKTAR THERAPEUTICS
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE